MBX Microbix Biosystems | C$0.30
| 6/5/2025 | D. Martin | Downgrade | Strong-Buy -> Moderate Buy | | View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 6/5/2025 |
RPTX Repare Therapeutics | $1.50
-0.7% | 1/10/2025 | D. Martin | Downgrade | Strong-Buy -> Hold | | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 1/10/2025 |
CYBN Cybin | $7.56
-1.7% | 5/2/2024 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of Cybin (OTCMKTS:CYBN) on 5/2/2024 |
RPTX Repare Therapeutics | $1.50
-0.7% | 4/19/2024 | D. Martin | Upgrade | Accumulate -> Buy | | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 4/19/2024 |
RPTX Repare Therapeutics | $1.50
-0.7% | 2/13/2024 | D. Martin | Downgrade | Buy -> Accumulate | | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 2/13/2024 |
MBX Microbix Biosystems | C$0.30
| 1/4/2024 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 1/4/2024 |
ABCL AbCellera Biologics | $4.24
-5.1% | 11/3/2023 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of AbCellera Biologics (NASDAQ:ABCL) on 11/3/2023 |
MDP Medexus Pharmaceuticals | C$2.66
-2.9% | 6/26/2023 | D. Martin | Upgrade | Hold -> Buy | | View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 6/26/2023 |
RX BioSyent | C$11.38
+0.6% | 3/23/2023 | D. Martin | Reiterated Rating | Accumulate | | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/23/2023 |
DOC CloudMD Software & Services | C$0.04
| 11/16/2022 | P. Pandurangan | Upgrade | Hold -> Accumulate | | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 11/16/2022 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
DOC CloudMD Software & Services | C$0.04
| 8/24/2022 | P. Pandurangan | Downgrade | Buy -> Hold | | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 8/24/2022 |
MDNA Medicenna Therapeutics | C$0.84
| 8/16/2022 | - | Lower Price Target | Buy | C$9.00 | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 8/16/2022 |
MDNA Medicenna Therapeutics | C$0.84
| 7/28/2022 | - | Reiterated Rating | Buy | C$11.00 | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 7/28/2022 |
HLS HLS Therapeutics | C$5.00
-0.6% | 7/26/2022 | - | Reiterated Rating | Buy | C$22.00 | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 7/26/2022 |
MBX Microbix Biosystems | C$0.30
| 6/6/2022 | A. Borovina | Reiterated Rating | Buy | | View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 6/6/2022 |
GUD Knight Therapeutics | C$6.17
+1.3% | 3/28/2022 | D. Martin | Reiterated Rating | Buy | C$6.70 | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/28/2022 |
GUD Knight Therapeutics | C$6.17
+1.3% | 3/25/2022 | D. Martin | Downgrade | Buy -> Accumulate | | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/25/2022 |
RX BioSyent | C$11.38
+0.6% | 3/10/2022 | D. Martin | Upgrade | Hold -> Accumulate | | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/10/2022 |
DOC CloudMD Software & Services | C$0.04
| 12/22/2021 | P. Pandurangan | Reiterated Rating | Buy | | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 12/22/2021 |
ABCL AbCellera Biologics | $4.24
-5.1% | 12/19/2021 | A. Borovina | Reiterated Rating | Buy | | View details for Bloom Burton rating of AbCellera Biologics (NASDAQ:ABCL) on 12/19/2021 |
AUPH Aurinia Pharmaceuticals | $10.49
+13.5% | 10/1/2021 | Prasath Pandurangan | Initiated Coverage | Hold | $23.00 | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 10/1/2021 |
RPTX Repare Therapeutics | $1.50
-0.7% | 9/30/2021 | Prasath Pandurangan | Initiated Coverage | Buy | $49.00 | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 9/30/2021 |
MDNA Medicenna Therapeutics | C$0.84
| 9/22/2021 | Prasath Pandurangan | Initiated Coverage | Buy | C$11.00 | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 9/22/2021 |
HLS HLS Therapeutics | C$5.00
-0.6% | 8/5/2021 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 8/5/2021 |
VMD Viemed Healthcare | $5.93
-2.6% | 8/4/2021 | P. Pandurangan | Upgrade | Accumulate -> Buy | | View details for Bloom Burton rating of Viemed Healthcare (NASDAQ:VMD) on 8/4/2021 |
AUPH Aurinia Pharmaceuticals | $10.49
+13.5% | 5/7/2021 | D. Martin | Upgrade | Accumulate -> Buy | | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 5/7/2021 |
GUD Knight Therapeutics | C$6.17
+1.3% | 3/26/2021 | D. Martin | Upgrade | Accumulate -> Buy | | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/26/2021 |
RX BioSyent | C$11.38
+0.6% | 3/18/2021 | D. Martin | Downgrade | Accumulate -> Hold | | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/18/2021 |
MDP Medexus Pharmaceuticals | C$2.66
-2.9% | 2/23/2021 | D. Martin | Upgrade | Accumulate -> Buy | | View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 2/23/2021 |
EPIX ESSA Pharma | $1.88
| 2/12/2021 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 2/12/2021 |
CRHM CRH Medical | $3.99
| 1/8/2021 | D. Martin | Downgrade | Hold | $3.00 | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 1/8/2021 |
CRHM CRH Medical | $3.99
| 12/23/2020 | D. Martin | Downgrade | Buy -> Hold | | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 12/23/2020 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/17/2020 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/17/2020 |
AUPH Aurinia Pharmaceuticals | $10.49
+13.5% | 11/3/2020 | D. Martin | Downgrade | Buy -> Accumulate | | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/3/2020 |
VMD Viemed Healthcare | $5.93
-2.6% | 10/19/2020 | P. Pandurangan | Reiterated Rating | Accumulate | | View details for Bloom Burton rating of Viemed Healthcare (NASDAQ:VMD) on 10/19/2020 |
RPTX Repare Therapeutics | $1.50
-0.7% | 9/17/2020 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 9/17/2020 |
HTL Hamilton Thorne | C$1.45
+4.3% | 8/21/2020 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of Hamilton Thorne (CVE:HTL) on 8/21/2020 |
XENE Xenon Pharmaceuticals | $30.50
-0.1% | 8/13/2020 | D. Martin | Reiterated Rating | Buy | $25.00 | View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 8/13/2020 |
CRH CRH | $95.31
-0.1% | 8/14/2020 | - | Reiterated Rating | Buy | | View details for Bloom Burton rating of CRH (NYSE:CRH) on 8/14/2020 |
CRHM CRH Medical | $3.99
| 8/13/2020 | D. Martin | Reiterated Rating | Buy | $4.00 | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/13/2020 |
Investigating the Most Controversial Stock on Earth (Ad) Tesla’s wild price swings may not be random after all.
Hedge fund veteran Larry Benedict has uncovered a strange pattern—what he calls the “Tesla Glitch”—that’s wiped out billions without warning… and then sent the stock surging hours later. He now says it ties directly back to the 2010 Flash Crash. Watch the exclusive Tesla Glitch interview and see how to trade it |
CRHM CRH Medical | $3.99
| 8/12/2020 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/12/2020 |
HLS HLS Therapeutics | C$5.00
-0.6% | 7/21/2020 | D. Martin | Upgrade | Accumulate -> Buy | | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 7/21/2020 |
GUD Knight Therapeutics | C$6.17
+1.3% | 6/29/2020 | D. Martin | Downgrade | Buy -> Accumulate | | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 6/29/2020 |
ZYME Zymeworks | $12.57
+0.1% | 6/14/2020 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of Zymeworks (NYSE:ZYME) on 6/14/2020 |
EPIX ESSA Pharma | $1.88
| 5/24/2020 | - | Reiterated Rating | Buy | $9.00 | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 5/24/2020 |
CPH Cipher Pharmaceuticals | C$12.17
+1.0% | 5/8/2020 | D. Martin | Upgrade | Hold -> Accumulate | | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 5/8/2020 |
HLS HLS Therapeutics | C$5.00
-0.6% | 3/31/2020 | D. Martin | Downgrade | Buy -> Accumulate | | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 3/31/2020 |
RX BioSyent | C$11.38
+0.6% | 3/19/2020 | D. Martin | Downgrade | Buy -> Accumulate | | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/19/2020 |
AUPH Aurinia Pharmaceuticals | $10.49
+13.5% | 3/19/2020 | D. Martin | Reiterated Rating | Buy | $23.00 | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 3/19/2020 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/12/2019 | D. Martin | Upgrade | Hold -> Buy | | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/12/2019 |
GUD Knight Therapeutics | C$6.17
+1.3% | 10/22/2019 | D. Martin | Upgrade | Accumulate -> Buy | | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 10/22/2019 |
HLS HLS Therapeutics | C$5.00
-0.6% | 10/4/2019 | D. Martin | Upgrade | Hold -> Buy | | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 10/4/2019 |
AUPH Aurinia Pharmaceuticals | $10.49
+13.5% | 10/2/2019 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 10/2/2019 |
RX BioSyent | C$11.38
+0.6% | 8/26/2019 | D. Martin | Upgrade | Accumulate -> Buy | | View details for Bloom Burton rating of BioSyent (CVE:RX) on 8/26/2019 |
CPH Cipher Pharmaceuticals | C$12.17
+1.0% | 8/12/2019 | D. Martin | Reiterated Rating | Hold | | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 8/12/2019 |
HLS HLS Therapeutics | C$5.00
-0.6% | 8/9/2019 | D. Martin | Downgrade | Buy -> Hold | | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 8/9/2019 |
CRHM CRH Medical | $3.99
| 8/1/2019 | D. Martin | Upgrade | Accumulate -> Buy | | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/1/2019 |
MDP Medexus Pharmaceuticals | C$2.66
-2.9% | 7/3/2019 | D. Martin | Reiterated Rating | Accumulate | | View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 7/3/2019 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 5/16/2019 | D. Martin | Downgrade | Buy -> Hold | | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/16/2019 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 4/1/2019 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 4/1/2019 |
HLS HLS Therapeutics | C$5.00
-0.6% | 3/22/2019 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 3/22/2019 |
CPH Cipher Pharmaceuticals | C$12.17
+1.0% | 3/20/2019 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 3/20/2019 |
CXRXF ADVANZ PHARMA | $17.06
| 3/15/2019 | D. Martin | Reiterated Rating | Hold | | View details for Bloom Burton rating of ADVANZ PHARMA (OTCMKTS:CXRXF) on 3/15/2019 |
GUD Knight Therapeutics | C$6.17
+1.3% | 11/9/2018 | D. Martin | Reiterated Rating | Accumulate | | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 11/9/2018 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 3/26/2018 | D. Martin | Upgrade | Accumulate -> Buy | | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 3/26/2018 |
RX BioSyent | C$11.38
+0.6% | 3/22/2018 | D. Martin | Reiterated Rating | Accumulate | | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/22/2018 |
EPI ESSA Pharma | C$8.20
+7.2% | 1/18/2018 | D. Martin | Upgrade | Hold -> Buy | | View details for Bloom Burton rating of ESSA Pharma (CVE:EPI) on 1/18/2018 |
EPIX ESSA Pharma | $1.88
| 1/18/2018 | D. Martin | Upgrade | Hold -> Buy | | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 1/18/2018 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/3/2017 | D. Martin | Downgrade | Buy -> Accumulate | | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/3/2017 |
HTL Hamilton Thorne | C$1.45
+4.3% | 10/25/2017 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of Hamilton Thorne (CVE:HTL) on 10/25/2017 |
EPIX ESSA Pharma | $1.88
| 9/12/2017 | D. Martin | Downgrade | Buy -> Hold | | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 9/12/2017 |
CPH Cipher Pharmaceuticals | C$12.17
+1.0% | 8/14/2017 | D. Martin | Downgrade | Buy -> Hold | | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 8/14/2017 |
CRHM CRH Medical | $3.99
| 7/14/2017 | D. Martin | Downgrade | Buy -> Accumulate | | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 7/14/2017 |
EPIX ESSA Pharma | $1.88
| 5/18/2017 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 5/18/2017 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 5/15/2017 | D. Martin | Upgrade | Hold -> Buy | | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/15/2017 |
CPH Cipher Pharmaceuticals | C$12.17
+1.0% | 5/12/2017 | D. Martin | Upgrade | Hold -> Buy | | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 5/12/2017 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 5/9/2017 | D. Martin | Downgrade | Accumulate -> Hold | | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/9/2017 |
CRHM CRH Medical | $3.99
| 2/24/2017 | D. Martin | Downgrade | Buy -> Accumulate | | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 2/24/2017 |
RX BioSyent | C$11.38
+0.6% | 2/13/2017 | D. Martin | Reiterated Rating | Accumulate | | View details for Bloom Burton rating of BioSyent (CVE:RX) on 2/13/2017 |
CPH Cipher Pharmaceuticals | C$12.17
+1.0% | 2/13/2017 | D. Martin | Reiterated Rating | Hold | | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 2/13/2017 |
ABUS Arbutus Biopharma | $3.27
-0.3% | 1/9/2017 | D. Martin | Upgrade | Accumulate -> Buy | | View details for Bloom Burton rating of Arbutus Biopharma (NASDAQ:ABUS) on 1/9/2017 |
XENE Xenon Pharmaceuticals | $30.50
-0.1% | 12/22/2016 | - | Initiated Coverage | Buy | $14.50 | View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 12/22/2016 |
ABUS Arbutus Biopharma | $3.27
-0.3% | 12/14/2016 | D. Martin | Reiterated Rating | Accumulate | | View details for Bloom Burton rating of Arbutus Biopharma (NASDAQ:ABUS) on 12/14/2016 |
GUD Knight Therapeutics | C$6.17
+1.3% | 11/10/2016 | D. Martin | Reiterated Rating | Accumulate | | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 11/10/2016 |
AUPH Aurinia Pharmaceuticals | $10.49
+13.5% | 11/4/2016 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/4/2016 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/2/2016 | D. Martin | Reiterated Rating | Accumulate | | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/2/2016 |
CRHM CRH Medical | $3.99
| 10/28/2016 | D. Martin | Reiterated Rating | Buy | | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 10/28/2016 |
ACHV Achieve Life Sciences | $2.55
-2.3% | 5/3/2013 | - | Boost Price Target | Buy | $4,000.00 -> $5,000.00 | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/3/2013 |
ACHV Achieve Life Sciences | $2.55
-2.3% | 3/8/2013 | - | Boost Price Target | | $3,600.00 -> $4,000.00 | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 3/8/2013 |
ONC Oncolytics Biotech | C$1.37
-2.1% | 12/18/2012 | - | Downgrade | Buy -> Hold | | View details for Bloom Burton rating of Oncolytics Biotech (TSE:ONC) on 12/18/2012 |
New Federal Land Rush About to Start? (Ad) A $100 Trillion Wealth Shift Is Already Underway
Lithium. Oil. Gold. Trillions in U.S. resources are being quietly opened to the public, and former hedge fund firm manager Whitney Tilson believes this is the best chance in years to turn a small stake into huge gains. He's naming one $10 stock leading this "US: IPO" boom. Click here to see the full story. |
THTX Theratechnologies | $3.16
+0.3% | 6/25/2012 | - | Downgrade | Hold -> Sell | $2.50 -> $0.75 | View details for Bloom Burton rating of Theratechnologies (NASDAQ:THTX) on 6/25/2012 |
ACHV Achieve Life Sciences | $2.55
-2.3% | 5/4/2012 | - | Lower Price Target | Buy | $3,800.00 -> $3,600.00 | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/4/2012 |
